Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
43,754,363
-
Total 13F shares
-
1,692,997
-
Share change
-
-188,140
-
Total reported value
-
$2,432,105
-
Price per share
-
$1.43
-
Number of holders
-
18
-
Value change
-
-$324,073
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) as of Q1 2023
As of 31 Mar 2023,
Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,692,997 shares.
The largest 10 holders included
AIGH Capital Management LLC, Worth Venture Partners, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Maven Securities LTD, STATE STREET CORP, MORGAN STANLEY, and Bank of New York Mellon Corp.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.